REFERENCES
[#2001-09] A Possible Hypoglycemic Effect of Maitake Mushroom on Type 2 Diabetes Patients, Sensuke Konno et al.
A Possible Hypoglycemic Effect of Maitake Mushroom on Type 2 Diabetes Patients Konno S, Tortorelis G, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H Department of Urology, New York Medical College Two patients diagnosed with Type 2 diabetes had significantly elevated fasting blood glucose (FBG) levels even with administration of glibenclamide, a commonly-prescribed diabetes drug. Both patients were given Maitake mushroom caplets (500 mg) in daily doses, along with their glibenclamide, and experienced a sharp drop in blood glucose levels to...
read more[#2001-08] Maitake SX-Fraction: Possible Hypoglycemic Effect on Diabetes Mellitus, Sensuke Konno
Maitake SX-Fraction: Possible Hypoglycemic Effect on Diabetes Mellitus Sensuke Konno, Ph.D. Diabetes mellitus is a metabolic disorder characterized by persistent hyperglycemia affecting more than 16 million people in the United States and some 250 million people worldwide.1 The prevalence of diabetes is increasing by 4–5 percent every year with an estimated 40–45 percent of people over 65 years old at risk.2 To enhance peripheral insulin sensitivity, pharmaceuticals, such as troglitazone8 and metformin,9,10 have been used. Although...
read more[#2001-07] Th1/Th2-Balancing Immunomodulating Activity of Gel-Forming (1→3)- β-Glucans from Fungi Maitake, Yoko Suzuki et al.
Th1/Th2-Balancing Immunomodulating Activity of Gel-Forming (1→3)- β-Glucans from Fungi Maitake Yoko SUZUKI, Yoshiyuki ADACHI, Naohito OHNO, and Toshiro YADOMAE Laboratory of Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Japan The immunomodulating effects of various gel-forming (1→3)-β-glucans, grifolan (GRN), SSG, sonifilan (SPG) and alkaline-treated SPG (SPG-OH), on balancing helper T cell activity were examined in a murine model. Plasma from mice that were injected with GRN...
read more[#2001-06] Purification and Characterization of an Aminopeptidase from the Edible Basidiomycete Grifola frondosa ( Maitake ), Toshikazu Nishiwaki et al.
Purification and Characterization of an Aminopeptidase from the Edible Basidiomycete Grifola frondosa ( Maitake ) Toshikazu NISHIWAKI and Kiyoshi HAYASHI National Food Research Institute, Ministry of Agriculture, Forestry, and Fisheries, Ibaraki Japan An aminopeptidase was purified 178-fold from an extract of Maitake ( Grifola frondosa ) by ammonium sulfate precipitation and a series of column chromatographies on phenyl-Toyopearl, Sephadex G-25, and Mono-Q. The molecular mass of the enzyme was estimated to be 27 kDa and 30 kDa...
read more[#2001-05] Purification and Characterization of Mushroom Proteases. 4. Maitake, Grifola frondosa, Emi Kenjo et al.
Purification and Characterization of Mushroom Proteases. 4. Maitake, Grifola frondosa Emi KENJO, Yoko YAMAGUCHI and Kosaku NODA Laboratory of Biochemistry, Department of Nutrition and Health Science, Faculty of Human Environmental Science, Fukuoka Women’s University, Japan Recently, proteolytic enzymes are becoming increasingly important especially in the food industries.” Today the major uses of proteases occur in production and processing of diverse products such as cheese,” 6) baked goods,7‘ beer,9‘...
read more[#2001-04] Relationship between Solubility of Grifolan, a Fungal 1,3-β-D-Glucan, and Production of Tumor Necrosis Factor by Macrophages in Vitro., K. Ishibashi et al.
Relationship between Solubility of Grifolan, a Fungal 1,3-β-D-Glucan, and Production of Tumor Necrosis Factor by Macrophages in Vitro. Ishibashi K, Miura NN, Adachi Y, Ohno N, Yadomae T. Laboratory for Immunopharmacology for Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science Grifolan, GRN, is a fungal antitumor β-glucan isolated from Grifola frondosa ( maitake ). Various studies suggested that the underlying mechanism of the antitumor activity of GRN is strongly related to immune modulation. In the previous...
read more[#2001-03] Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice, Noriko Kodama et al.
Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice Kodama N, Yamada M, Nanba H. Department of Microbial Chemistry, Kobe Pharmaceutical University Maitake D-fraction, β1,6-glucan having β,3-branches, has been reported to activate the immune system of the host. To elucidate whether the D-fraction can reduce the clinical effective dosage of antibiotics in the treatment of opportunistic bacterial infection, we examined the effects of D-fraction on the treatment of Listeria...
read more[#2001-02] Maitake Extract and Their Therapeutic Potential — A Review, Mark Mayell
Maitake Extract and Their Therapeutic Potential — A Review Mark Mayell Abstract Maiitake (Grifola frondosa) is the Japanese name for an edible fungus with a large fruiting body characterized by overlapping caps. It is a premier culinary as well as medicinal mushroom, Maitake is increasingly being recognized as a potent source of polysaccharide compounds with dramatic health-promoting potential. The most recent development is the MD-fraction, a proprietary maitake extract its Japanese inventors consider to be a notable advance upon the...
read more[#2001-01] Effects of maitake (Grifola frondosa) D-Fraction on the carcinoma angiogenesis, K Matsui et al.
Effects of maitake (Grifola frondosa) D-Fraction on the carcinoma angiogenesis Matsui K, Kodama N, Nanba H. Department of Microbial chemistry, Kobe Pharmaceutical University We have reported that D-Fraction extracted from maitake (Grifola frondosa), activates immune competent cells, and indicates anti-tumor activities. The D-Fraction was observed to induce angiogenesis in vivo and to enhance the proliferation capability and migration capability of human vascular endothelial cell in vitro. The D-Fraction also increased plasma vascular...
read more[#2000-10] Tremella Reshetnikov, Sergey V. et al Medicinal Value of the Genus Tremella Pers. (Heterobasidiomycetes) Review
Medicinal Value of the Genus Tremella Pers. (Heterobasidiomycetes) (Review) Sergey V Reshetnikov,1‘3 Solomon P Wasser,1‘2 Eviatar Nevo,2 Ina Duckman,3 and Katherina Tsukor3 1N. G. Kholodny Institute of Botany, National Academy of Sciences of Ukraine, Ukraine; 2 lnstitute of Evolution, University of Haifa, Mt. Carmel, Israel; 3 Med Myco Ltd., Institute of Evolution, University of Haifa, Israel ABSTRACT: Jelly mushrooms from the genus Tremella have been known in Oriental medicine for hundreds of years as beneficial for...
read more